Startup profile · funding coverage
Hippocratic AI
Healthcare LLM company focused on safety-tuned models for patient-facing clinical workflows.
Stage
growth
Status
private
Coverage
full
Why Hippocratic AI is interesting
Hippocratic AI is betting that healthcare needs domain-tuned, safety-first models — not general chatbots. Core to a16z’s healthcare AI allocation.
Key facts
- Seed (2023): a16z Bio+Health backed $50M seed (Fierce Healthcare)
- Series A (Mar 2024): $53M co-led by Premji Invest and General Catalyst; Kleiner Perkins in Series C (2025) (Hippocratic AI)
Investors in our directory
Funds linked from Hippocratic AI's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech AI & Machine Learning
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
FAQs about Hippocratic AI
Funding context and why this company shows up in venture coverage.
Hippocratic AI develops healthcare-specific LLMs designed for safe, patient-facing clinical workflows like outreach and care navigation.
Andreessen Horowitz (see /fund/andreessen-horowitz), General Catalyst (/fund/general-catalyst), and Kleiner Perkins (/fund/kleiner-perkins) are among publicly listed backers.
Hippocratic AI raised a $50M seed in 2023, a $53M Series A in March 2024, and a Series C in 2025 with Kleiner Perkins participation.
Healthcare needs domain-tuned, safety-first models — not general chatbots — for regulated patient interactions.
Hippocratic AI remains private as of July 2026.
Last updated: 2026-07-24